1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT | BSE: 524742
Ask AI about Caplin Point Labs
2631.90-84.50(-3.11%)
161.2K
NSE+BSE Volume

NSE 01 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Caplin Point Labs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Caplin Point Labs share price target, revenues, EPS, net income and more

Caplin Point Labs quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Caplin Point Labs Jun-2026 Quarterly Revenue is Rs 266 Cr which is growth of 23.8% YoY.

  • POSITIVE

    Quarterly Net Profit Caplin Point Labs Jun-2026 Quarterly Net Profit is Rs 120 Cr which is growth of 40.2% YoY.

Caplin Point Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
⌄
265.7252.4221234.4214.6214.9214.1250.9207.1175.6150.7203.7200.9
Operating Exp.
108.5107.897.599.39698.6107.8109.8104.381.769.589.897
Operating Profit
94.483.691.775.986.67577.498.281.457.763.389.576.6
Operating Profit Margin %
46.52%43.68%48.47%43.30%47.44%43.22%41.78%47.21%43.84%41.38%47.67%49.91%44.12%
Depr.
6.66.96.466.16.166.56.26.96.86.76.7
Interest
0.10.10.10.1000000000
Profit Before Tax
150.6137.7117129112.5110.2100.2134.796.786.974.4107.297.2
Tax
30.228.229.726.426.623.725.528.924.1171925.120.9
Net Profit
120.4109.587.3102.685.986.574.7105.772.569.955.582.176.3
EPS Adj. latest
15.814.411.513.511.311.49.813.99.59.27.310.810
Net profit TTM
419.8385.3362.3349.7352.8339.5322.9303.6280283.7268.1271.9247.3
Basic EPS TTM
55.250.747.74646.444.742.54036.837.435.335.832.6
Earnings Transcripts
Results PDF
 
Result Notes
 
*All financials are in INR Cr and price data in INR

Caplin Point Labs competitor comparison and performance snapshot within industry

Caplin Point Labs annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • POSITIVE

    Annual Revenue Caplin Point Labs Mar-2026 Annual Revenue is Rs 934 Cr which is growth of 5.3% YoY.

  • POSITIVE

    Annual Net Profit Caplin Point Labs Mar-2026 Annual Net Profit is Rs 397 Cr which is growth of 16.8% YoY.

Caplin Point Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
14.2%
13.2%
973.5933.7887730.9627.6584.6501.3593.8572.3449.9354.1234.8
Operating Exp. Ann.
9.1%
8.3%
413.1400.6420.4338308.7308.4268.8320.8348.8284.8248.1169
Operating Profit Ann.
15.4%
9.6%
345.6337.8332287.1219.9219.6213.9207188.2141.893.562.3
OPM Ann. %
1.1%
-3.2%
 36.18%37.43%39.28%35.04%37.57%42.67%34.86%32.88%31.52%26.39%26.54%
⌄
8.4%
7.9%
 426.2445.3365.2334.5334.3291.4340.7369.7303.8261.5176.4
EBITDA Ann.
18.7%
18.1%
 533.2466.6392.9318.9276.2232.5273223.6165.110665.8
EBITDA Ann. margin %
4%
4.2%
 57.10%52.60%53.76%50.81%47.24%46.39%45.97%39.06%36.70%29.93%28.02%
Interest Ann.
26%
0%
0.20.20.10.10.10.10.20.20.10.10.10.1
Depr.
-0.4%
2.5%
25.925.424.827.125.725.822.419.720.81913.37.3
PBT Ann.
20.1%
19.3%
534.3507.5441.7365.7293.2250.3209.9253.1202.7146.192.658.4
Tax Ann.
23.5%
15.6%
114.6110.9102.28258.962.453.755.554.543.722.313.1
19.2%
20.5%
 396.6339.5283.7234.3187.9156.2197.6148.2102.370.345.3
Net Profit Ann.
19.2%
20.5%
419.8396.6339.5283.7234.3187.9156.2197.6148.2102.370.345.3
NPM Ann. %
6.6%
10.7%
 53.71%45.12%45.38%44.31%35.57%32.36%37.44%27.59%23.98%20.58%19.59%
EPS Adj. latest Ann.
19.2%
20.4%
 52.244.737.330.824.720.62619.513.59.36
Result Notes
   
Annual Reports
 
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
5.3%
2Y CAGR
13%
3Y CAGR
14.2%
5Y CAGR
13.2%
7Y CAGR
7.2%
10Y CAGR
14.8%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
16.8%
2Y CAGR
18.2%
3Y CAGR
19.2%
5Y CAGR
20.5%
7Y CAGR
15.1%
10Y CAGR
24.2%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
-4.7%
2Y CAGR
8.9%
3Y CAGR
9.1%
5Y CAGR
8.3%
7Y CAGR
2%
10Y CAGR
9%
Operating Expenses Annual Cr is falling faster than historical averages.

Caplin Point Labs balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Caplin Point Labs Mar-2026 Total Shareholders Fund is Rs 2,050 Cr which is growth of 20.6% YoY.

  • POSITIVE

    Total Assets Caplin Point Labs Mar-2026 Total Assets is Rs 2,212 Cr which is growth of 21.9% YoY.

Caplin Point Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
⌄
21.6%
22%
2,050.51,700.91,390.21,139.9930.7758.7599.9432295.6200.1128.1
Minority Interest Liability Ann.
-
-
-----------
⌄
1.4%
-7.3%
17.113.712.916.424.62527.224.827.919.913.7
-0.6%
13.3%
144.299.9119.3146.998.977.364.382.587.397.1120.8
Total Capital Plus Liabilities Ann.
19.3%
20.8%
2,211.71,814.51,522.31,303.21,054.2861691.3539.3410.8317.1262.6
⌄
5.2%
4.8%
232.3225.9193.5199.5165.1184.1170.7146.4184.6155.2143
⌄
24.6%
30.4%
1,235.9988.8819.2639.2448.5328.4310.6251.4197.6180.3147.8
13.7%
12.9%
975.9825.7703.1664605.7532.7380.7288213.2136.7114.8
Total Assets Ann.
19.3%
20.8%
2,211.71,814.51,522.31,303.21,054.2861691.3539.3410.8317.1262.6
Contingent Liabilities plus Commitments Ann.
-5.1%
10.1%
72.364.83784.636.844.626.674.674.27.6
Bonus Equity Share Capital Ann.
-
-
Non Current Investments Unquoted Book Value Ann.
-
-
703.7490.2345.10.30.31.61.4
Current Investments Unquoted Book Value Ann.
-
224.7%
252.80.75.44.2
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
21.9%
2Y CAGR
20.5%
3Y CAGR
19.3%
5Y CAGR
20.8%
7Y CAGR
22.3%
10Y CAGR
23.7%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
44.3%
2Y CAGR
9.9%
3Y CAGR
-0.6%
5Y CAGR
13.3%
7Y CAGR
8.3%
10Y CAGR
1.8%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
20.6%
2Y CAGR
21.4%
3Y CAGR
21.6%
5Y CAGR
22%
7Y CAGR
24.9%
10Y CAGR
32%
Total ShareHolders Funds Annual growth is lower than historical averages.

Caplin Point Labs ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • POSITIVE

    Book Value Per Share Caplin Point Labs Mar-2026 Book Value Per Share is 270 Rs which is growth of 20.6% YoY.

  • POSITIVE

    ROE Caplin Point Labs Mar-2026 ROE is 19% which is growth of 0.6% YoY.

Caplin Point Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
BVSH Ann.
21.6%
21.9%
269.8223.8183150.2122.8100.379.357.139.126.582.3
RoA Ann. %
-0.1%
-0.2%
17.93%18.71%18.63%17.97%17.82%18.14%28.58%27.47%24.90%22.17%17.26%
ROE Ann. %
-2%
-1.2%
19.34%19.95%20.40%20.55%20.18%20.59%32.94%34.29%34.61%35.13%36.43%
ROCE Ann. %
-1.1%
-1.7%
24.55%25.76%26.07%25.36%26.21%26.81%40.39%44.37%45.17%42.13%41.23%
⌄
           
⌄
           
⌄
           
Total Debt to Total Equity Ann.
          0
*All financials are in INR Cr and price data in INR
ROE Ann. %
1Y CHG
-3.1%
2Y CAGR
-2.6%
3Y CAGR
-2%
5Y CAGR
-1.2%
7Y CAGR
-7.9%
10Y CAGR
-6.1%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-4.2%
2Y CAGR
-1.9%
3Y CAGR
-0.1%
5Y CAGR
-0.2%
7Y CAGR
-5.9%
10Y CAGR
0.4%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
-18.1%
2Y CAGR
7.4%
3Y CAGR
14.8%
5Y CAGR
-0.3%
7Y CAGR
10%
10Y CAGR
21.1%
Current Ratio Annual is falling faster than historical averages.

Caplin Point Labs cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • POSITIVE

    Cash From Operating Activity Caplin Point Labs Mar-2026 Cash From Operating Activity is Rs 203 Cr which is growth of 3.9% YoY.

  • NEGATIVE

    Net Cash Flow Caplin Point Labs Mar-2026 Net Cash Flow is Rs -56 Cr which is growth of -417.6% YoY.

Caplin Point Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17Mar '16
9%
-7.1%
203.5195.9111157.1231294.787107.322.655.544.4
Cash from Investing Act. Ann.
-
-
-213.5-140.2-118.9-86.7-237.216.3-41.1-76.5-59.7-37.1-6
Cash from Financing Act. Ann.
-
-
-45.8-38.1-34.3-30.4-22.8-3.5-32.9-15.2-11.6-6.7-14
-
-
-55.817.6-42.240-29307.51315.6-48.711.724.5
*All financials are in INR Cr and price data in INR
Cash from Operating Act. Ann.
1Y CHG
3.9%
2Y CAGR
35.4%
3Y CAGR
9%
5Y CAGR
-7.1%
7Y CAGR
9.6%
10Y CAGR
16.4%
Cash from Operating Activity Annual growth is stable compared to historical averages.

Caplin Point Labs investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access